Insider · CIK 0001889633
Pinos Elisabet de los
Files at AURA (Aura Biosciences, Inc.). First filing Nov 1, 2023, latest Feb 17, 2026.
In brief
Pinos Elisabet de los files SEC Form 4 as officer and director at AURA (Aura Biosciences, Inc.). Since Nov 1, 2023, Pinos Elisabet de los has reported 0 open-market buys worth $0 and 10 open-market sells worth $1.3M, the latest filed on Feb 17, 2026.
A track record needs three past buys with six months of prices behind them; Pinos Elisabet de los has 0, so none is measured yet.
The newest scored trade: sold $241k of AURA on Feb 17, 2026, filed Feb 17, 2026, scored 48 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $381k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AURA: Aura Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Aura Biosciences, Inc. | $241k 47,648 shares | -10% | +7% from low-31% from high | |
| 32Weak | Aura Biosciences, Inc. | $82k 16,928 shares | -4% | +1% from low-39% from high | |
| 37Weak | Aura Biosciences, Inc. | $57k 9,049 shares | -2% | +25% from low-45% from high | |
| 41Moderate | Aura Biosciences, Inc. | $157k 20,221 shares | -4% | - | |
| 33Weak | Aura Biosciences, Inc. | $122k 15,955 shares | -5% | - | |
| 40Moderate | Aura Biosciences, Inc. | $99k 9,200 shares | -3% | - | |
| 9Weak | Aura Biosciences, Inc. | $301k 24,992 shares | -7% | - | |
| 33Weak | Aura Biosciences, Inc. | $121k 15,853 shares | -9% | +9% from low-43% from high | |
| 0Weak | Aura Biosciences, Inc. | $90k 7,449 shares | -4% | +52% from low-23% from high | |
| 31Weak | Aura Biosciences, Inc. | $65k 9,586 shares | -5% | +3% from low-48% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | AURA Aura Biosciences, Inc. | 47,648 0.07% of outstanding | $241k | Feb 17, 2026 | $82k |
| Jan 20, 2026 | AURA Aura Biosciences, Inc. | 16,928 0.03% of outstanding | $82k | Jan 20, 2026 | $57k |
| Oct 29, 2025 | AURA Aura Biosciences, Inc. | 9,049 0.01% of outstanding | $57k | Oct 29, 2025 | none |
| Feb 18, 2025 | AURA Aura Biosciences, Inc. | 20,221 0.04% of outstanding | $157k | Feb 18, 2025 | $122k |
| Jan 21, 2025 | AURA Aura Biosciences, Inc. | 15,955 0.03% of outstanding | $122k | Jan 21, 2025 | $99k |
| Oct 29, 2024 | AURA Aura Biosciences, Inc. | 9,200 0.02% of outstanding | $99k | Oct 29, 2024 | $232k |
| Oct 18, 2024 | AURA AURA BIOSCIENCES INC | 24,992 0.05% of outstanding | $257k | Oct 18, 2024 | none |
| Jan 24, 2024 | AURA Aura Biosciences, Inc. | 15,853 0.03% of outstanding | $121k | Jan 23, 2024 | $155k |
| Nov 6, 2023 | AURA AURA BIOSCIENCES INC | 30,149 0.08% of outstanding | $361k | Nov 6, 2023 | $65k |
| Nov 3, 2023 | AURA Aura Biosciences, Inc. | 9,586 0.03% of outstanding | $65k | Oct 30, 2023 | none |
Transactions
Every row this insider has filed, 23 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +166,000 | $0.00 | $0 | 575,815 | Mar 3, 2026 |
| Mar 2, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +249,000 | $0.00 | $0 | 249,000 | Mar 3, 2026 |
| Feb 17, 2026 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -47,648 | $5.06 | $241k | 409,815 | Feb 17, 2026 |
| Jan 20, 2026 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -16,928 | $4.86 | $82k | 457,463 | Jan 20, 2026 |
| Oct 29, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -9,049 | $6.35 | $57k | 474,391 | Oct 29, 2025 |
| Jun 2, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock | +10,948 | $5.07 | $56k | 493,388 | Jun 4, 2025 |
| Jun 2, 2025 | AURA Aura Biosciences, Inc. | FTax withholding Common Stock | -9,948 | $6.16 | $61k | 483,440 | Jun 4, 2025 |
| Jun 2, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -10,948 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Feb 18, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -20,221 | $7.75 | $157k | 482,440 | Feb 18, 2025 |
| Feb 3, 2025 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +194,320 | $0.00 | $0 | 502,661 | Feb 4, 2025 |
| Feb 3, 2025 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +255,680 | $0.00 | $0 | 255,680 | Feb 4, 2025 |
| Jan 21, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -15,955 | $7.67 | $122k | 304,692 | Jan 21, 2025 |
| Oct 29, 2024 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -9,200 | $10.74 | $99k | 320,647 | Oct 29, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +24,992 | $2.74 | $68k | 354,839 | Oct 18, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -24,992 | $12.04 | $301k | 329,847 | Oct 18, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -24,992 | $0.00 | $0 | 336,171 | Oct 18, 2024 |
| Feb 1, 2024 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +162,935 | $0.00 | $0 | 324,373 | Feb 2, 2024 |
| Feb 1, 2024 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +237,065 | $0.00 | $0 | 237,065 | Feb 2, 2024 |
| Jan 23, 2024 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -15,853 | $7.64 | $121k | 161,438 | Jan 24, 2024 |
| Nov 6, 2023 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +3,800 | $2.74 | $10k | 184,740 | Nov 7, 2023 |
| Nov 6, 2023 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -7,449 | $12.03 | $90k | 177,291 | Nov 7, 2023 |
| Nov 6, 2023 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,800 | $0.00 | $0 | 361,163 | Nov 7, 2023 |
| Oct 30, 2023 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -9,586 | $6.83 | $65k | 180,940 | Nov 1, 2023 |
Questions about Pinos Elisabet de los
Answered from the filings on this page, as of the latest one.
Is Pinos Elisabet de los buying or selling?
In the last 12 months Pinos Elisabet de los reported 0 open-market buys worth $0 and 3 open-market sells worth $381k on SEC Form 4; the latest was sold $241k of AURA on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Pinos Elisabet de los's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pinos Elisabet de los has 0.
Where does Pinos Elisabet de los file Form 4?
Pinos Elisabet de los has filed Form 4 at AURA (Aura Biosciences, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.